Reaction Details |
| Report a problem with these data |
Target | Receptor-interacting serine/threonine-protein kinase 1 |
---|
Ligand | BDBM36371 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | Enzyme Immuno Assay |
---|
IC50 | 95.5±n/a nM |
---|
Citation | Kim, E; Yoo, S; Kang, NS; Koo, T; Park, M; Kim, Y; Bae, H; Kim, J; In, T; Joo, C Fused heterocyclic ring compounds and method of treating retinal disease using same US Patent US10501473 Publication Date 12/10/2019 |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Receptor-interacting serine/threonine-protein kinase 1 |
---|
Name: | Receptor-interacting serine/threonine-protein kinase 1 |
Synonyms: | Cell death protein RIP | RIP | RIP-1 | RIP1 | RIPK1 | RIPK1_HUMAN | Receptor-interacting protein 1 |
Type: | Enzyme Catalytic Domain |
Mol. Mass.: | 75926.99 |
Organism: | Homo sapiens (Human) |
Description: | Q13546 |
Residue: | 671 |
Sequence: | MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEAL
LEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIIL
EIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVD
GTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMC
IKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEED
VKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFA
PSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPF
AQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLD
PGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQ
IGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKN
CARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRID
LLSSLIYVSQN
|
|
|
BDBM36371 |
---|
n/a |
---|
Name | BDBM36371 |
Synonyms: | 5-(1H-indol-3-ylmethyl)-3-methyl-2-thioxo-4-Imidazolidinone, Nec-1 | CID2828334 | US10501473, Comparative Example 1 |
Type | Small organic molecule |
Emp. Form. | C13H13N3OS |
Mol. Mass. | 259.327 |
SMILES | CN1C(=S)NC(Cc2c[nH]c3ccccc23)C1=O |
Structure |
|